Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)-Reference-Cited by-同舟云学术

Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)

Published:2021-09-08 Issue:5 Volume:46 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Zeng Yongqin¹,Lv Xiuzhi²,Du Juan³

Affiliation:

1. Department of Nephrology, The Affiliated Hospital Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China

2. Department of Pulmonary and Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China

3. Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single cell transcriptomic analysis reveals tumor immune infiltration by NK cells gene signature in lung adenocarcinoma;Heliyon;2024-07

2. BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3;Nature Communications;2024-03-22

3. Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study;Journal for ImmunoTherapy of Cancer;2024-03

4. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment;Regenerative Engineering and Translational Medicine;2024-03-01

5. A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer;Frontiers in Immunology;2024-02-01